Table 2.
Baseline laboratory investigations in children with dilated cardiomyopathy associated with vitamin D deficiency
| Parameters | Total cases (n = 14) |
|---|---|
| Blood glucose (mg%), median (IQR) | 92 (85–104) |
| Lactate (mmol/L), median (IQR) | 3.2 (2.6–4.2) |
| Ionized calcium (mmol/L), median (IQR) | 0.7 (0.7–1.1) |
| Total calcium (mg%), median (IQR) | 8.7 (7–9.5) |
| Phosphate (mg/dL), median (IQR) | 3.5 (2.6–4.5) |
| Alkaline phosphatase levels (IU/L), median (IQR) | 343 (316–415) |
| 25(OH)D3 levels (ng/mL), median (IQR) | 5 (3–7) |
| PTH levels (pg/mL), median (IQR) | 115 (66–228) |
| Serum aspartate transaminase (U/L) median (IQR) | 59 (37–272) |
| Serum alanine transaminase, (U/L), median (IQR) | 44 (23–180) |
| CK-MB (IU/L), median (IQR) | 42 (34–54) |
| Hb (gm/dL), median (IQR) | 8.8 (8.0–9.8) |
| Total leukocyte count (per cumm), median (IQR) | 13,900 (9552–15,100) |
| Platelet count (units), median (IQR) | 3,52,500 (2,30,250–4,14,000) |
| Urea, (mg%), median (IQR) | 34 (21.7–55) |
| Creatinine (units), median (IQR) | 0.3 (0.2–0.5) |
| Left ventricular ejection fraction (%) at admission, median (IQR) | 22 (17–25) |
| LVEF <30%, n (%) | 13 (92.9) |
| LVEF 31–40%, n (%) | 1 (7.1) |